ARCHIVES

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014

In Brief: Cigarette Tax Would Raise $12 Million A Year for Pennsylvania Cancer Control, Research

August 5, 1977

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995